ema-adama
07-08-09, 11:39 PM
http://www.ncbi.nlm.nih.gov/pubmed/19359104?ordinalpos=17&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsP anel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Incidence and virulence of Clostridium difficile-associated disease (CDAD) is increasing, particularly in institutional settings. Morbidity, mortality, and costs associated with this condition are high. Broad-spectrum antibiotics have long been recognized as the primary risk factor for CDAD due to disruption of protective normal gastrointestinal flora.
Really? I am quite sure this is not being taught at medical school. Definitly not in 2008.
Routine use of probiotics within institutional settings may substantially decrease healthcare costs.
What a novel idea????
Incidence and virulence of Clostridium difficile-associated disease (CDAD) is increasing, particularly in institutional settings. Morbidity, mortality, and costs associated with this condition are high. Broad-spectrum antibiotics have long been recognized as the primary risk factor for CDAD due to disruption of protective normal gastrointestinal flora.
Really? I am quite sure this is not being taught at medical school. Definitly not in 2008.
Routine use of probiotics within institutional settings may substantially decrease healthcare costs.
What a novel idea????